OLD National Bancorp IN Raises Position in Bath & Body Works, Inc. $BBWI

OLD National Bancorp IN increased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 20.0% in the 1st quarter, HoldingsChannel reports. The firm owned 499,165 shares of the company’s stock after purchasing an additional 83,059 shares during the period. OLD National Bancorp IN’s holdings in Bath & Body Works were worth $9,319,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. AQR Capital Management LLC boosted its holdings in Bath & Body Works by 132.5% in the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after purchasing an additional 6,523,960 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Bath & Body Works by 2,204.1% during the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock worth $133,292,000 after buying an additional 4,949,796 shares in the last quarter. Norges Bank acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $55,504,000. Balyasny Asset Management L.P. acquired a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $54,785,000. Finally, Bank of America Corp DE boosted its stake in shares of Bath & Body Works by 86.9% in the third quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock valued at $87,568,000 after buying an additional 1,580,176 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

BBWI opened at $22.93 on Friday. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96. The stock has a market cap of $4.62 billion, a P/E ratio of 6.44, a P/E/G ratio of 2.16 and a beta of 1.42. The stock’s 50 day simple moving average is $19.14 and its 200 day simple moving average is $20.28.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works’s revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts expect that Bath & Body Works, Inc. will post 2.62 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 3.5%. The ex-dividend date of this dividend was Friday, June 5th. Bath & Body Works’s payout ratio is 22.47%.

Analysts Set New Price Targets

BBWI has been the topic of a number of recent analyst reports. Weiss Ratings lowered Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. Barclays decreased their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 28th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research note on Tuesday. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Finally, TD Cowen increased their price target on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Hold” and an average target price of $22.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.